These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31125176)

  • 21. 2'-Fucosyllactose Ameliorates Oxidative Stress Damage in d-Galactose-Induced Aging Mice by Regulating Gut Microbiota and AMPK/SIRT1/FOXO1 Pathway.
    Wang J; Hu JQ; Song YJ; Yin J; Wang YY; Peng B; Zhang BW; Liu JM; Dong L; Wang S
    Foods; 2022 Jan; 11(2):. PubMed ID: 35053883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.
    Yu ZT; Nanthakumar NN; Newburg DS
    J Nutr; 2016 Oct; 146(10):1980-1990. PubMed ID: 27629573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose.
    Salli K; Anglenius H; Hirvonen J; Hibberd AA; Ahonen I; Saarinen MT; Tiihonen K; Maukonen J; Ouwehand AC
    Sci Rep; 2019 Sep; 9(1):13232. PubMed ID: 31520068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Milk Oligosaccharide 2'-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin.
    Mukherjee R; Somovilla VJ; Chiodo F; Bruijns S; Pieters RJ; Garssen J; van Kooyk Y; Kraneveld AD; van Bergenhenegouwen J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats.
    Van Ommen B; De Bie AT; Bär A
    Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2'-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression.
    Yao Q; Fan L; Zheng N; Blecker C; Delcenserie V; Li H; Wang J
    Front Nutr; 2022; 9():822020. PubMed ID: 35252301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2'-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome.
    Kim YJ; Kim HH; Shin CS; Yoon JW; Jeon SM; Song YH; Kim KY; Kim K
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of
    Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P
    Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load.
    Obermeier S; Rudloff S; Pohlentz G; Lentze MJ; Kunz C
    Isotopes Environ Health Stud; 1999; 35(1-2):119-25. PubMed ID: 10902537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactooligosaccharide or 2'-Fucosyllactose Modulates Gut Microbiota and Inhibits LPS/TLR4/NF-κB Signaling Pathway to Prevent DSS-Induced Colitis Aggravated by a High-Fructose Diet in Mice.
    Chen T; Wang C; Nie C; Yuan X; Tu A; Li J
    J Agric Food Chem; 2023 Jun; 71(24):9349-9360. PubMed ID: 37290013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infants Fed Breastmilk or 2'-FL Supplemented Formula Have Similar Systemic Levels of Microbiota-Derived Secondary Bile Acids.
    Hill DR; Buck RH
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering the Substrate Transport and Cofactor Regeneration Systems for Enhancing 2'-Fucosyllactose Synthesis in
    Deng J; Gu L; Chen T; Huang H; Yin X; Lv X; Liu Y; Li N; Liu Z; Li J; Du G; Liu L
    ACS Synth Biol; 2019 Oct; 8(10):2418-2427. PubMed ID: 31550146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Human Milk Oligosaccharides and
    Salli K; Hirvonen J; Anglenius H; Hibberd AA; Ahonen I; Saarinen MT; Maukonen J; Ouwehand AC
    Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human milk oligosaccharides reduce necrotizing enterocolitis-induced neuroinflammation and cognitive impairment in mice.
    Sodhi CP; Ahmad R; Fulton WB; Lopez CM; Eke BO; Scheese D; Duess JW; Steinway SN; Raouf Z; Moore H; Tsuboi K; Sampah ME; Jang HS; Buck RH; Hill DR; Niemiro GM; Prindle T; Wang S; Wang M; Jia H; Catazaro J; Lu P; Hackam DJ
    Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G23-G41. PubMed ID: 37120853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying the human milk oligosaccharides 2'-fucosyllactose and 3-fucosyllactose in different food applications by high-performance liquid chromatography with refractive index detection.
    Christensen AS; Skov SH; Lendal SE; Hornshøj BH
    J Food Sci; 2020 Feb; 85(2):332-339. PubMed ID: 31968133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a quantitative assay for 2´-fucosyllactose via one-pot reaction with α1,2-fucosidase and l-fucose dehydrogenase.
    Seydametova E; Shin J; Yu SH; Kim C; Kim H; Park YJ; Yang JK; Cho S; Kim HR; Moon SO; Ban C; Kweon DH
    Anal Biochem; 2019 Oct; 582():113358. PubMed ID: 31278898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective microbial production of lacto-N-fucopentaose I in Escherichia coli using engineered α-1,2-fucosyltransferases.
    Endo S; Sugita T; Kamai S; Nakamura K; Yamazaki F; Sampei S; Snarskis G; Valančiūtė A; Kazemi M; Rokaitis I; Koketsu K
    Metab Eng; 2024 Mar; 82():1-11. PubMed ID: 38145749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced bioproduction of fucosylated oligosaccharide 3-fucosyllactose in engineered Escherichia coli with an improved de novo pathway.
    Ni Z; Wu J; Li Z; Yuan L; Wang Y; Chen X; Yao J
    Biosci Biotechnol Biochem; 2021 Jun; 85(7):1772-1781. PubMed ID: 33904902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous production of 2'-fucosyllactose and difucosyllactose by engineered Escherichia coli with high secretion efficiency.
    Lee HJ; Shin DJ; Han K; Chin YW; Park JP; Park K; Choi CH; Park BR; Kim SJ; Kim SK
    Biotechnol J; 2022 Mar; 17(3):e2100629. PubMed ID: 35073455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 21-day safety evaluation of biotechnologically produced 3-fucosyllactose (3-FL) in neonatal farm piglets to support use in infant formulas.
    Pitt J; Bond J; Roper J; Tenning P; Mukherjea R; Evans K; Saarinen MT; Anglenius H; Hirvonen J; Hasselwander O; Lim A
    Food Chem Toxicol; 2024 May; 187():114592. PubMed ID: 38493976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.